Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Autoimmune & immunology R&D Pipeline

Autoimmune, rheumatology, and immunology biologics in clinical development.

Programs 985

Quick answer

Autoimmune & immunology: NovaPharmaNews indexes 985 autoimmune & immunology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Autoimmune, rheumatology, and immunology biologics in clinical development.

Top sponsors

Pipeline programs

Page 11 of 21

  1. Etanercept

    United Therapeutics Europe Ltd

    Lupus Erythematosus, Discoid

    phase 2 small molecule completed

    1 trial

  2. Etrasimod

    Arena Pharmaceutical Enterprises Limited

    Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

  3. FT819

    Zafatek

    Lupus Nephritis

    phase 2 mab active

    1 trial

  4. FX005

    Pacira Ireland Limited

    Osteoarthritis, Knee

    phase 2 small molecule completed

    1 trial

  5. FX006

    Pacira Ireland Limited

    Osteoarthritis of the Shoulder

    phase 2 small molecule terminated

    1 trial

  6. FX006 10 mg

    Pacira Ireland Limited

    Osteoarthritis of the Knee

    phase 2 small molecule completed

    2 trials

  7. FX006 32 mg

    Pacira Ireland Limited

    Bilateral Knee Osteoarthritis

    phase 2 small molecule completed

    1 trial

  8. FX006 32 mg

    Pacira Ireland Limited

    Post-traumatic Osteoarthritis of the Knee

    phase 2 small molecule terminated

    1 trial

  9. FX006 32 mg

    Pacira Ireland Limited

    Osteoarthritis of the Shoulder

    phase 2 small molecule completed

    1 trial

  10. FX006 32 mg

    Pacira Ireland Limited

    Osteoarthritis, Hip

    phase 2 small molecule completed

    1 trial

  11. Filgotinib

    Lakefront Biotherapeutics NV

    Fistulizing Crohn's Disease

    phase 2 small molecule completed

    1 trial

  12. Filgotinib

    Lakefront Biotherapeutics NV

    Small Bowel Crohn's Disease

    phase 2 small molecule completed

    1 trial

  13. Fostamatinib

    AstraZeneca

    Rheumatoid Arthritis

    phase 2 small molecule terminated

    1 trial

  14. Fostamatinib 150 mg bid

    RIGEL PHARMACEUTICALS INC

    Warm Antibody Autoimmune Hemolytic Anemia

    phase 2 small molecule completed

    1 trial

  15. Fostamatinib Disodium (R935788)

    RIGEL PHARMACEUTICALS INC

    Systemic Lupus Erythematosus

    phase 2 small molecule terminated

    1 trial

  16. Fostamatinib disodium (R935788)

    RIGEL PHARMACEUTICALS INC

    Rheumatoid Arthritis

    phase 2 small molecule completed

    2 trials

  17. Frexalimab, Matched Placebo for Test

    Sanofi-aventis Healthcare Pty Ltd

    Systemic lupus erythematosus

    phase 2 small molecule active

    1 trial

  18. GLPG0259 oral capsule

    Lakefront Biotherapeutics NV

    Rheumatoid Arthritis

    phase 2 small molecule completed

    1 trial

  19. GLPG0634

    Lakefront Biotherapeutics NV

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  20. GLPG0634

    Lakefront Biotherapeutics NV

    Rheumatoid Arthritis

    phase 2 small molecule completed

    4 trials

  21. GLPG0974

    Lakefront Biotherapeutics NV

    Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

  22. GLPG1205

    Lakefront Biotherapeutics NV

    Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

  23. GLPG1972

    Lakefront Biotherapeutics NV

    Osteoarthritis

    phase 2 small molecule completed

    1 trial

  24. GLPG3667

    Lakefront Biotherapeutics NV

    Systemic Lupus Erythematosus

    phase 2 small molecule completed

    1 trial

  25. GLPG3970

    Lakefront Biotherapeutics NV

    Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

  26. GLPG3970

    Lakefront Biotherapeutics NV

    Rheumatoid Arthritis

    phase 2 small molecule completed

    1 trial

  27. GR-MD-02

    GALECTIN THERAPEUTICS INC

    Psoriasis

    phase 2 small molecule completed

    1 trial

  28. GS-US-409-5704

    Gilead Sciences Pty Limited

    Ulcerative Colitis (UC)

    phase 2 small molecule active

    1 trial

  29. GSK3196165 Dose 1

    GlaxoSmithKline

    Arthritis, Rheumatoid

    phase 2 small molecule completed

    1 trial

  30. Glutamine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatic Heart Disease

    phase 2 small molecule completed

    1 trial

  31. Guselkumab

    Janssen Cilag International NV

    Colitis, Ulcerative

    phase 2 mab active

    1 trial

  32. HZNP-DAX-202

    Elan Pharma International

    Primary Discoid Lupus Erythematosus

    phase 2 small molecule active

    1 trial

  33. Human Umbilical Cord derived MSCs

    CytoMed Therapeutics Ltd

    Lupus Nephritis

    phase 2 mab active

    1 trial

  34. Huzhang granule

    Universal Integrated

    Gouty Arthritis

    phase 2 small molecule active

    1 trial

  35. I7P-MC-DSAG

    Eli Lilly Co.

    Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  36. ICP-022

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

    Systemic Lupus Erythematosus

    phase 2 small molecule completed

    1 trial

  37. IDOR-1117-2520 matching placebo

    Lacuna Pharma Pty Ltd

    Moderate to severe chronic plaque psoriasis

    phase 2 small molecule active

    1 trial

  38. IRX4204

    IO Biotech

    Psoriasis

    phase 2 small molecule on hold

    1 trial

  39. ISIS 104838

    IONIS PHARMACEUTICALS INC

    Rheumatoid Arthritis

    phase 2 small molecule completed

    1 trial

  40. ISIS CRP Rx or Placebo

    IONIS PHARMACEUTICALS INC

    Rheumatoid Arthritis

    phase 2 small molecule completed

    1 trial

  41. Ibuprofen-PC

    Protalix BioTherapeutics

    Osteoarthritis

    phase 2 small molecule completed

    1 trial

  42. Imsidolimab

    Vanda Pharmaceuticals Netherlands B.V.

    Generalized Pustular Psoriasis

    phase 2 mab completed

    1 trial

  43. Indigo naturalis ointment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Psoriasis

    phase 2 small molecule completed

    1 trial

  44. J6E-MC-KWAN

    Eli Lilly Co.

    Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  45. JBT-101

    Corbus Pharmaceuticals Holdings

    Systemic Lupus Erythematosus

    phase 2 small molecule completed

    1 trial

  46. JNJ-77242113

    Janssen Cilag International NV

    Colitis, Ulcerative

    phase 2 small molecule completed

    1 trial

  47. JNJ-81241459 for Plaque Psoriasis

    Janssen-Cilag International N.V.

    Plaque Psoriasis

    phase 2 small molecule active

    1 trial

  48. JY231 injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Systemic Lupus Erythematosus (SLE)

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many autoimmune & immunology pipeline programs are tracked?

985 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.